Tergene, is a biotech company promoted by a scientist turned entrepreneur with a vision of providing quality human biologics.

Tergene is developing bio-conjugate platform technologies for novel vaccines and antibody drug conjugates. A basket of vaccines against bacterial pneumonia is under various stages of development.

Tergene's upcoming GMP facility at Hyderabad, India is expected to be operational by the end of 2014. The facility would be used for the manufacture of vaccines, biopharmaceuticals and probiotics.

Vision & Mission

Tergene's Vision is to deliver the best quality, cost-effective biologics to all categories of people.

Tergene's Mission is to improve the quality of life thus creating a healthier world.

News

"Mission - Vaccine to fight pneumonia deaths" - Biospectrum magazine, Nov 2011. Read...

Products

Tergene offers GLP grade Diphtheria toxin CRM 197 as lyophilized powder. CRM 197 is used as carrier protein in the development of conjugate vaccines. For further information contact info@tergene.com

GLP grade Pneumococcal capsular polysaccharides of various serotypes are available as lyophilized powder. For further information contact info@tergene.com